Genpact LTD G
- Market cap
- $6.9B
- PE
- 12.1×
- 10y median 21.6×
- Forward PE
- n/m
- not a meaningful number
- Price to sales
- 1.3×
- EV/EBIT
- 9.5×
- Revenue, 12 months
- $5.3B
- +7% on a year ago
- Net margin
- 11.1%
- Free cash flow yield
- 8.3%
Genpact LTD trades at 12.1× trailing earnings, cheaper than 86% of the last ten years. Revenue was $5.3B over the last twelve months, up 7% on a year earlier with a 11% net margin.
Charts
Financials
| Income statement | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $1.1B+2% | $1.1B+4% | $1.1B+4% | $1.2B+6% | $1.2B+7% | $1.2B+9% | $1.2B+7% | $1.3B+7% | $1.3B+7% | $1.3B+6% | $1.3B+7% | $1.3B+7% | |
| Cost of revenue | $733M+2% | $738.7M+3% | $734.8M+2% | $759.8M+6% | $779.5M+6% | $803M+9% | $785.9M+7% | $804.4M+6% | $821.6M+5% | $837M+4% | $824.4M+5% | $853.1M+6% |
| Gross profit | $402.8M+2% | $407.6M+6% | $396.5M+7% | $416.4M+7% | $431.4M+7% | $445.8M+9% | $429M+8% | $450.1M+8% | $469.7M+9% | $482.3M+8% | $471.7M+10% | $490.3M+9% |
| SG&A | $229.7M−1% | $237.4M+0% | $235M+9% | $239.6M+5% | $243.3M+6% | $249.2M+5% | $241.1M+3% | $266.4M+11% | $262.1M+8% | $277.1M+11% | $270.3M+12% | $294.1M+10% |
| $165.7M+27% | $162.7M+27% | $160M+10% | $170.3M+8% | $181.7M+10% | $190.2M+17% | $183.7M+15% | $179.4M+5% | $191.6M+6% | $195.5M+3% | $198.6M+8% | $192.9M+8% | |
| Pre-tax income | $154.9M+28% | $158.5M+29% | $156.4M+13% | $162.4M+8% | $175.5M+13% | $182.5M+15% | $175.2M+12% | $176.7M+9% | $189.4M+8% | $188.8M+3% | $194M+11% | $190.9M+8% |
| $37.3M+48% | −$132.8M | $39.4M+22% | $40.4M+19% | $42.7M+14% | $40.6M | $44.4M+13% | $44M+9% | $43.5M+2% | $45.7M+13% | $46M+4% | $45.1M+3% | |
| Net income | $117.6M+23% | $291.3M+225% | $116.9M+10% | $122M+5% | $132.8M+13% | $141.9M−51% | $130.9M+12% | $132.7M+9% | $145.8M+10% | $143.1M+1% | $148M+13% | $145.7M+10% |
| $0.64+26% | $1.59+231% | $0.64+12% | $0.67+6% | $0.74+16% | $0.79−50% | $0.73+14% | $0.75+12% | $0.83+12% | $0.82+4% | $0.86+18% | $0.86+15% | |
| 183.8M−2% | 183.4M−2% | 181.9M−3% | 180.9M−3% | 179.7M−2% | 179.2M−2% | 178.4M−2% | 177.1M−2% | 176.1M−2% | 175M−2% | 172.8M−3% | 170.4M−4% |
EPS, diluted: 8 periods, Q4 FY09 to Q4 FY25: quarter's net income to common over its shares, to the cent.
Diluted shares: 7 periods, Q4 FY09 to Q4 FY25: share-days: the 12-month average less the 9-month, weighted by days.
From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.
Peers
Companies in Consulting Services nearest Genpact LTD's size, closest first.
| Company | Market cap | PE | Its 10y median PE | Fwd PE | P/S | Revenue growth | Net margin |
|---|---|---|---|---|---|---|---|
| GGenpact LTD | $6.9B | 12.1× | 21.6× | 1.3× | +7% | 11.1% | |
| BAHBooz Allen Hamilton | $9.4B | 12.3× | 21.5× | 0.8× | −7% | 7.0% | |
| FCNFTI Consulting | $4.3B | 19.0× | 22.0× | 1.1× | +7% | 6.4% | |
| EXPOExponent | $3.7B | 34.7× | 46.6× | 5.8× | +13% | 17.7% | |
| HURNHuron Consulting | $3.1B | 29.3× | 25.9× | 1.7× | +14% | 6.4% | |
| EFXEquifax | $21.4B | 32.0× | 41.1× | 3.3× | +10% | 10.7% | |
| ASTHAstrana Health | $2.1B | 45.7× | 35.1× | 0.5× | +59% | 1.1% | |
| ICFIICF International | $1.7B | 19.5× | 23.2× | 0.9× | −8% | 4.9% | |
| BWMNBowman Consulting | $742.5M | 107× | 106× | 1.4× | +14% | 1.4% | |
| Peer median | $3.4B | 30.7× | 30.5× | 1.3× | +12% | 6.4% |
More on Genpact LTD
Each number over time
- PE ratio
- Price to sales ratio
- EV/EBIT
- Price to free cash flow
- Price to book ratio
- Market cap
- Revenue
- EPS
- Free cash flow
- Profit margin
- Shares outstanding
Where it ranks
- #1of 13Consulting Services stocks with the lowest PE ratio
- #2of 17Consulting Services stocks with the highest profit margins
- #2of 16Consulting Services stocks with the lowest EV/EBIT
- #2of 10Consulting Services stocks cheapest against their own PE history
- #8of 17Consulting Services stocks with the highest free cash flow yield
- #6of 12Consulting Services stocks with the fastest earnings growth
- #9of 17Consulting Services stocks with the fastest revenue growth
Its groups
About
- Industry
- Consulting Services
- Sector
- Industrials
Valuation data, not investment advice. Prices as of .